APTEVO THERAPEUTICS
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. They leverage the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients.Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
APTEVO THERAPEUTICS
Industry:
Biometrics Biopharma Biotechnology Oncology
Founded:
2016-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.aptevotherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
(888)616-0855
Total Funding:
56.95 M USD
Technology used in webpage:
Domain Not Resolving Euro U.S. Server Location
Similar Organizations
ArcherDX
ArcherDX is a biotechnology firm specializing in cancer research.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Current Advisors List
Board_member
Current Employees Featured
Barbara Lopez Kunz Director @ Aptevo Therapeutics
Director
2017-01-01
SoYoung Kwon Senior Vice President, General Counsel, Corporate Affairs, Human Resources @ Aptevo Therapeutics
Senior Vice President, General Counsel, Corporate Affairs, Human Resources
2021-01-01
Jeff Lamothe SVP & Chief Financial Officer @ Aptevo Therapeutics
SVP & Chief Financial Officer
2012-01-01
Scott Stromatt CMO & Senior Vice President @ Aptevo Therapeutics
CMO & Senior Vice President
2008-08-01
Marvin L. White President & CEO @ Aptevo Therapeutics
President & CEO
Founder
Stock Details
Official Site Inspections
http://www.aptevotherapeutics.com Semrush global rank: 8.35 M Semrush visits lastest month: 558
- Host name: client-23-254-131-60.hostwindsdns.com
- IP address: 23.254.131.60
- Location: Seattle United States
- Latitude: 47.4902
- Longitude: -122.3004
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98168
More informations about "Aptevo Therapeutics"
About Us - Aptevo Therapeutics
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative and proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create …See details»
Management Team - Aptevo Therapeutics
He also previously served as President and Chief Executive Officer of Kitchen Craft Cabinetry, after occupying the position of VP of Finance and Chief Financial Officer with the organization. …See details»
Aptevo Therapeutics - Crunchbase Company Profile
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. They leverage the …See details»
Aptevo Therapeutics Inc - LinkedIn
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. We leverage the innovative ADAPTIR™ platform technology, a unique ...See details»
Aptevo Therapeutics Inc. (APVO)
See the company profile for Aptevo Therapeutics Inc. (APVO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Aptevo Therapeutics - Overview, News & Similar companies
Aug 11, 2024 Explore Complete Organization Structure. Is Aptevo Therapeutics your ideal customer? ... 838-0500 Website: aptevotherapeutics.com What does Aptevo Therapeutics do? …See details»
Aptevo Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aptevo Therapeutics Inc. of Seattle, WA. Get the latest business insights from Dun & Bradstreet.See details»
Aptevo Therapeutics (APVO) Company Profile & Description
2401 4th Avenue, Suite 1050 Seattle, Washington 98121 United StatesSee details»
Aptevo Therapeutics - PitchBook
Aptevo Therapeutics General Information Description. Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel …See details»
Aptevo Therapeutics - Craft
Oct 29, 2024 Aptevo Therapeutics has 3 employees at their 1 location and $3.11 m in annual revenue in FY 2022. See insights on Aptevo Therapeutics including office locations, …See details»
Board of Directors - Aptevo Therapeutics
Prior to this role, he served as Vice President of Sales for Tissue Tech Limited, an organization who pioneered the innovative application of human placental tissue in wound healing. From …See details»
Bispecific Antibody, APVO442, Differentiated to Treat Prostate …
Dec 4, 2024 aptevotherapeutics.com . Aptevo Therapeutics 2401 4th Avenue Suite 1050 Seattle, WA 98121 . More Press Releases. RAINIER Trial Data Update: Two Additional AML …See details»
Aptevo Therapeutics Inc. Company Profile & Executives - WSJ
Company profile for Aptevo Therapeutics Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed APVO description & address.See details»
Aptevo Therapeutics, Inc. - Drug pipelines, Patents, Clinical
For more information, please visit www.aptevotherapeutics.com . Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities …See details»
Aptevo Therapeutics Inc. (APVO) - Yahoo Finance Canada
See the company profile for Aptevo Therapeutics Inc. (APVO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important …
Nov 11, 2024 The Aptevo mission is to improve treatment outcomes and transform the lives of cancer patients. For more information, please visit www.aptevotherapeutics.com. About …See details»
Aptevo Therapeutics Inc, AP80:FRA profile - FT.com - Financial Times
Mar 6, 2024 Aptevo Therapeutics Inc (AP80:FRA) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Aptevo Therapeutics (APVO) Stock Price, News & Analysis
5 days ago www.aptevotherapeutics.com. Phone (206) 838-0500. Fax 206-838-0503. Employees 50. Year Founded 2016. Price Target and Rating. Average Stock Price Target …See details»
Aptevo Therapeutics Inc. | Insights
Apr 7, 2023 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Aptevo Highlights APVO603: A Novel Bispecific Antibody
Mar 19, 2025 The Aptevo mission is to improve treatment outcomes and transform the lives of cancer patients. For more information, please visit www.aptevotherapeutics.com. Safe Harbor …See details»